首页> 外文期刊>Pediatric asthma, allergy & immunology >The Use of Bilevel Positive Airway Pressure in a Tertiary Care Pediatric Intensive Care Unit
【24h】

The Use of Bilevel Positive Airway Pressure in a Tertiary Care Pediatric Intensive Care Unit

机译:双水平气道正压在三级护理小儿重症监护室中的使用

获取原文
获取原文并翻译 | 示例
           

摘要

Bilevel positive airway pressure therapy (bilevel therapy) is a useful tool for noninvasive ventilation in a pediatric intensive care unit (ICU). The objective of this study was to evaluate use of bilevel therapy in a tertiary care pediatric ICU by retrospective chart review. All patients during the study period (April, 2000, to June, 2003) who received mechanical ventilation were included (189 total): 94 received bilevel therapy (group 1) and 95 underwent invasive mechanical ventilation during the same time (group 2). None were excluded. A database was developed and analyzed. Data between groups were analyzed using t test and chi-square. Mean age of total sample was 9.20 years ± 5.536 SD; mean weight, 26.49 kg ± 16.68 SD. Mean age of group 1 was 10.87 yrs ± 0.50166 SD; mean weight, 30.46 kg ± 17.490 SD. A higher number of patients treated with bilevel therapy had acute respiratory failure (ARF) of infectious etiology or postoperative respiratory failure compared with primary airway compromise or ARF associated with other organ system dysfunction (p = 0.0001.) Patients with cerebral palsy, spinal muscular atrophy, or muscular dystrophy received bilevel therapy (p = 0.001, 0.034, and 0.013, respectively). Patients with postoperative respiratory insufficiency received bilevel therapy (p = 0.022). Mean age of group 2 was 7.55 years ± 5.584 SD; mean weight, 22.57 kg ± 14.91 SD. Group 2 had higher incidence of more than one organ system dysfunction (p = 0.019). Nosocomial tracheitis or ventilator-associated pneumonia were prevalent in group 2 (p = 0.020). We believe bilevel therapy is successful in older, heavier patients who have an acute respiratory infection or postoperative respiratory distress or insufficiency, with an underlying diagnosis of cerebral palsy or muscle disease. Those with ARF combined with other organ dysfunction required invasive mechanical ventilation.
机译:双水平气道正压疗法(双水平疗法)是用于儿科重症监护病房(ICU)的无创通气的有用工具。这项研究的目的是通过回顾性图表审查来评估在三级护理小儿ICU中使用双水平疗法。研究期间(2000年4月至2003年6月)所有接受机械通气的患者(共189例):94例接受了双层治疗(第1组),95例同时接受了有创机械通气(第2组)。没有一个被排除在外。开发并分析了数据库。使用t检验和卡方检验分析组之间的数据。总样本的平均年龄为9.20岁±5.536 SD;平均重量,26.49公斤±16.68标准差。第一组的平均年龄为10.87岁±0.50166 SD;平均重量,30.46公斤±17.490 SD。与原发性气道损害或与其他器官系统功能障碍相关的ARF相比,接受双水平疗法治疗的患者有更多的感染性病因或术后呼吸衰竭的急性呼吸衰竭(ARF)(p = 0.0001。)脑瘫,脊髓性肌萎缩的患者或肌营养不良症接受了双水平治疗(分别为0.001、0.034和0.013)。术后呼吸功能不全的患者接受了双水平治疗(p = 0.022)。第2组的平均年龄为7.55岁±5.584 SD;平均重量,22.57公斤±14.91 SD。第2组的发生率高于一种器官系统功能障碍(p = 0.019)。第2组中普遍存在医院内气管炎或呼吸机相关性肺炎(p = 0.020)。我们相信双水平疗法在患有急性呼吸道感染或术后呼吸窘迫或功能不全且诊断为脑瘫或肌肉疾病的较重,较重的患者中是成功的。患有ARF并伴有其他器官功能障碍的患者需要有创机械通气。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号